Examination Report |
1 | TM-A(TRADE MARKS APPLICATION) | 17 Apr 2017 |
2 | TM-O(NOTICE OF OPPOSITION) | 07 Oct 2017 |
3 | Journal Copy | 26 Oct 2017 |
4 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 28 Nov 2018 |
5 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 28 Nov 2018 |
6 | TM-M(CORRECTION OF CLERICAL ERROR OR FOR AMENDMENT U/R 37) | 29 May 2019 |
1 | Opposition Notice | 5310867 | 2258524 | 31 Oct 2017 |
2 | Opposition Counter Statement | 5630726 | 2404012 | 29 Dec 2017 |
Trademark was applied on 17 April 2017 with IP India.
Proprietor of Diclophase is CLARIS INJECTABLES.
Class(es) in which the trademark was applied to is 5.
Status of Diclophase is Opposed.
Application number alloted to the trademark is 3526825.
Trademark has been filed in the following category:
WORD